HeartSciences (HSCSW) Capital Expenditures (2022 - 2024)

HeartSciences (HSCSW) has reported Capital Expenditures for 3 consecutive years, with $48799.0 the latest figure, recorded in Q2 2024.

• For the quarter ending Q2 2024, Capital Expenditures rose 542.77% year-over-year to $48799.0; the trailing twelve-month figure through Apr 2026 stood at $48799.0 (down 15.27% YoY), and the FY2026 full-year result was $3554.0, up 12.58% from the prior year.
• Capital Expenditures climbed to $48799.0 in Q2 2024 per HSCSW's latest filing, from $8794.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $48799.0 in Q2 2024 and bottomed at $1952.0 in Q4 2023.
• Historically, Capital Expenditures has averaged $11823.3 across 3 years, with a median of $7247.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures sank 32.25% in 2023, then jumped 542.77% in 2024.
• Over 3 years, Capital Expenditures stood at $7247.0 in 2022, then slumped by 73.06% to $1952.0 in 2023, then soared by 2399.95% to $48799.0 in 2024.
• According to Business Quant data, Capital Expenditures over the past three periods registered $48799.0, $8794.0, and $1952.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.